Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Lipocine Inc (NASDAQ:LPCN)

3.89
Delayed Data
As of Sep 23
 +0.06 / +1.57%
Today’s Change
2.51
Today|||52-Week Range
16.30
-69.91%
Year-to-Date
Royce Micro-Cap Fund Semi-Annual Letter Summary
Sep 22 / GuruFocus News - Paid Partner Content
Royce Low-Price Stock Fund Semiannual Letter
Sep 19 / GuruFocus News - Paid Partner Content

Today’s Trading

Previous close3.83
Today’s open3.83
Day’s range3.74 - 3.94
Volume116,662
Average volume (3 months)408,595
Market cap$71.0M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+30.63%
Earnings growth (this year)-14.11%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.69

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...0.000.00%
EPIXESSA Pharma Inc-0.05-2.00%
VCELVericel Corp+0.28+10.61%
BLRXBioLine RX Ltd+0.27+26.73%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 10, 2016
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$18.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Mahesh V. Patel
CFO, Principal Accounting Officer &
EVP
Morgan R. Brown
Corporate headquarters
Salt Lake City, Utah

Forecasts

Search for Jobs